Interleukin-6 signaling pathway in targeted therapy for cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin-6 signaling pathway in targeted therapy for cancer

Published:2012-11 Issue:7 Volume:38 Page:904-910
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Guo Yuqi,Xu Feng,Lu TianJian,Duan Zhenfeng,Zhang Zhan

Funder

The National Cancer Institute, NIH (Nanotechnology Platform)

the Ovarian Cancer Research Foundation (OCRF)

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference125 articles.

1. Interleukin-6 in bone metastasis and cancer progression;Ara;Eur J Cancer,2010

2. Interleukin-6: discovery of a pleiotropic cytokine;Kishimoto;Arthritis Res Ther,2006

3. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3;Fielding;J Immunol,2008

4. Inflammation, HCC and sex: IL-6 in the centre of the triangle;Prieto;J Hepatol,2008

5. IL-6: a multifunctional regulator of immunity and inflammation;Paul;Jpn J Cancer Res,1991

Cited by 573 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis;Annals of Medicine;2024-09-09

2. The Protective Effects of Mcl-1 on Mitochondrial Damage and Oxidative Stress in Imiquimod-Induced Cancer Cell Death;Cancers;2024-09-02

3. MiR-137 mediated high expression of TIGD1 promotes migration, invasion, and suppresses apoptosis of lung adenocarcinoma;Lung Cancer;2024-09

4. Interleukin-6 in relation to early recurrence in primary, localized soft tissue sarcoma: An addition for existing risk classification systems?;European Journal of Surgical Oncology;2024-09

5. A Mathematical Model Simulating the Adaptive Immune Response in Various Vaccines and Vaccination Strategies;2024-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3